Trial Information

Summary: Are you interested in alternative investigational methods to possibly keep your ULCERATIVE COLITIS in remission?

If you or someone you know suffers from ulcerative colitis, you know that this disease is far from pleasurable. HOPE Research Institute is looking for adults to participate in a clinical research study evaluating the safety and efficiency of taking Asacol once daily compared to twice daily in maintaining remission in patients with ulcerative colitis.

Qualified study participants will receive study supervision by a board-certified gastroenterologist, study-related procedures and medication at no charge. Qualified participants will receive compensation for their time and travel.

Eligibility Criteria:

• Are you 18 years of age or older?
• Do you have history of ulcerative colitis?
• Are you taking Asacol on a daily basis for the past 3 months?

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:44:23 AM